Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-30
Seidman Christine E Files Merck & Co. (MRK) Form 4 - September 30, 2026
Seidman Christine E reported holdings changes in MRK in this Form 4 filing, reported to the SEC on 2026-09-30.
- Insider
- Seidman Christine E
- Issuer
- Merck & Co., Inc. MRK · NYSE
- Filed
- Period
- 2026-09-30
- Accession
- 0000310158-26-000234
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| No transactions found | ||||||
About Merck & Co., Inc.
Merck & Co., Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, biologic therapies, and animal health products. The company’s pharmaceutical business serves areas such as oncology, immunology, infectious diseases, cardiometabolic conditions, neuroscience, and hospital care, while its vaccine portfolio supports preventive care across pediatric, adolescent, and adult populations. Merck & Co., Inc. also operates an animal health segment that provides veterinary pharmaceuticals, vaccines, and health management solutions for livestock and companion animals. Its products are distributed through healthcare providers, wholesalers, pharmacies, hospitals, veterinarians, and government channels, giving the company a broad role across human and animal health markets. Headquartered in Rahway, New Jersey, Merck & Co., Inc. is recognized for its research-intensive model and its presence in essential therapeutic and preventive care categories worldwide.
Track MRK insider activity
Get alerted when Merck & Co., Inc. executives buy or sell their shares.